|
SDCBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.839100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.898000E-02 |
| Normal-vs-Stage2 |
2.291500E-02 |
| Normal-vs-Stage3 |
2.482600E-03 |
| Normal-vs-Stage4 |
1.157570E-02 |
| Stage1-vs-Stage2 |
5.138200E-01 |
| Stage1-vs-Stage3 |
2.001400E-01 |
| Stage1-vs-Stage4 |
5.336800E-01 |
| Stage2-vs-Stage3 |
7.211600E-01 |
| Stage2-vs-Stage4 |
8.916200E-01 |
| Stage3-vs-Stage4 |
5.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.210700E-04 |
| Normal-vs-AfricanAmerican |
8.899800E-01 |
| Normal-vs-Asian |
8.843000E-01 |
| Caucasian-vs-AfricanAmerican |
1.744790E-01 |
| Caucasian-vs-Asian |
2.625000E-01 |
| AfricanAmerican-vs-Asian |
9.722800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.988200E-04 |
| Normal-vs-Female |
5.682400E-02 |
| Male-vs-Female |
3.380600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.284100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.456000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.757200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.479700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.685800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.592600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.834600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.243200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.947760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.654200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.660400E-01 |
| Normal-vs-Grade 2 |
1.298020E-02 |
| Normal-vs-Grade 3 |
3.183300E-03 |
| Normal-vs-Grade 4 |
1.297530E-02 |
| Grade 1-vs-Grade 2 |
3.438000E-01 |
| Grade 1-vs-Grade 3 |
3.132400E-01 |
| Grade 1-vs-Grade 4 |
3.256400E-01 |
| Grade 2-vs-Grade 3 |
5.114400E-01 |
| Grade 2-vs-Grade 4 |
7.494200E-01 |
| Grade 3-vs-Grade 4 |
8.488600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.035640E-03 |
| Normal-vs-ccB subtype |
1.122000E-01 |
| ccA subtype-vs-ccB subtype |
7.130500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.187750E-02 |
| Normal-vs-N1 |
5.301600E-01 |
| N0-vs-N1 |
5.110600E-01 |
|
|
